Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980054845> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2980054845 endingPage "1781" @default.
- W2980054845 startingPage "1781" @default.
- W2980054845 abstract "Abstract Introduction Patients with follicular lymphomas (FL) often follow an indolent disease course initiated with the wait-and-watch approach. Chemotherapy, including rituximab (R), is inevitably required in most patients though. R-maintenance is indicated for patients achieving a partial or complete remission based results from randomized clinical trials and confirmed by meta-analyses demonstrating a prolonged progression free survival. A benefit in overall survival (OS), however, has yet to be established in the first line setting. Patients and methods We completed a retrospective analysis in patients extracted from the Danish National Lymphoma Register. Eligible patient data included histopathological confirmation of FL diagnosed in the period 2000-2014 who received R-Chemotherapy as first line treatment and surviving a minimum 1 year after treatment initiation. A Cox regression model was performed, adjusted for age, gender, stage, response rates and treatment period (pre-maintenance era (year 2000-2010) vs. maintenance era (year 2011-2014)) with hazard ratio (HR) of OS as the primary endpoint. All patients were followed until June 2016. Results 1037 patients were extracted from the register. 481 patients received R-maintenance (RM-group) and 556 patients did not. The median age was 62 (26-90), 526 (51%) were male, LDH was elevated in 325 (31%) and 436 (42%) had a high FLIPI index. The median follow-up time was 6.3 years. The five year OS for all patients was 86%. A significant change in the chemotherapy regimens was observed between the two groups, since Bendamustine was more frequently used in the maintenance group. A significant lower HR was observed in the RM group with a HR of 0.63 (95% CI 0.44 - 0.88, P = 0.008). Furthermore, gender proved of significance, with a HR for men of 1.78 (95% CI 1.32-2.40, P < 0.001). Conclusions Rituximab maintenance treatment following first line immunochemotherapy in patients with follicular lymphoma improved survival in a large population based cohort of patients and consolidates this strategy as part of the standard of care in this patient group. Disclosures No relevant conflicts of interest to declare." @default.
- W2980054845 created "2019-10-18" @default.
- W2980054845 creator A5002570069 @default.
- W2980054845 creator A5010830740 @default.
- W2980054845 creator A5018751853 @default.
- W2980054845 creator A5022110617 @default.
- W2980054845 creator A5026722843 @default.
- W2980054845 creator A5031476005 @default.
- W2980054845 creator A5033498376 @default.
- W2980054845 creator A5037713780 @default.
- W2980054845 creator A5040068557 @default.
- W2980054845 creator A5055309337 @default.
- W2980054845 creator A5058033035 @default.
- W2980054845 date "2016-12-02" @default.
- W2980054845 modified "2023-10-01" @default.
- W2980054845 title "Rituximab Maintenance after First Line Immunochemotherapy Improves Overall Survival in Patients with Follicular Lymphoma" @default.
- W2980054845 doi "https://doi.org/10.1182/blood.v128.22.1781.1781" @default.
- W2980054845 hasPublicationYear "2016" @default.
- W2980054845 type Work @default.
- W2980054845 sameAs 2980054845 @default.
- W2980054845 citedByCount "2" @default.
- W2980054845 countsByYear W29800548452018 @default.
- W2980054845 countsByYear W29800548452020 @default.
- W2980054845 crossrefType "journal-article" @default.
- W2980054845 hasAuthorship W2980054845A5002570069 @default.
- W2980054845 hasAuthorship W2980054845A5010830740 @default.
- W2980054845 hasAuthorship W2980054845A5018751853 @default.
- W2980054845 hasAuthorship W2980054845A5022110617 @default.
- W2980054845 hasAuthorship W2980054845A5026722843 @default.
- W2980054845 hasAuthorship W2980054845A5031476005 @default.
- W2980054845 hasAuthorship W2980054845A5033498376 @default.
- W2980054845 hasAuthorship W2980054845A5037713780 @default.
- W2980054845 hasAuthorship W2980054845A5040068557 @default.
- W2980054845 hasAuthorship W2980054845A5055309337 @default.
- W2980054845 hasAuthorship W2980054845A5058033035 @default.
- W2980054845 hasConcept C126322002 @default.
- W2980054845 hasConcept C141071460 @default.
- W2980054845 hasConcept C168563851 @default.
- W2980054845 hasConcept C203092338 @default.
- W2980054845 hasConcept C207103383 @default.
- W2980054845 hasConcept C2776694085 @default.
- W2980054845 hasConcept C2777058707 @default.
- W2980054845 hasConcept C2778283404 @default.
- W2980054845 hasConcept C2778336483 @default.
- W2980054845 hasConcept C2779338263 @default.
- W2980054845 hasConcept C2780653079 @default.
- W2980054845 hasConcept C2780739268 @default.
- W2980054845 hasConcept C2781442060 @default.
- W2980054845 hasConcept C44249647 @default.
- W2980054845 hasConcept C50382708 @default.
- W2980054845 hasConcept C71924100 @default.
- W2980054845 hasConceptScore W2980054845C126322002 @default.
- W2980054845 hasConceptScore W2980054845C141071460 @default.
- W2980054845 hasConceptScore W2980054845C168563851 @default.
- W2980054845 hasConceptScore W2980054845C203092338 @default.
- W2980054845 hasConceptScore W2980054845C207103383 @default.
- W2980054845 hasConceptScore W2980054845C2776694085 @default.
- W2980054845 hasConceptScore W2980054845C2777058707 @default.
- W2980054845 hasConceptScore W2980054845C2778283404 @default.
- W2980054845 hasConceptScore W2980054845C2778336483 @default.
- W2980054845 hasConceptScore W2980054845C2779338263 @default.
- W2980054845 hasConceptScore W2980054845C2780653079 @default.
- W2980054845 hasConceptScore W2980054845C2780739268 @default.
- W2980054845 hasConceptScore W2980054845C2781442060 @default.
- W2980054845 hasConceptScore W2980054845C44249647 @default.
- W2980054845 hasConceptScore W2980054845C50382708 @default.
- W2980054845 hasConceptScore W2980054845C71924100 @default.
- W2980054845 hasIssue "22" @default.
- W2980054845 hasLocation W29800548451 @default.
- W2980054845 hasOpenAccess W2980054845 @default.
- W2980054845 hasPrimaryLocation W29800548451 @default.
- W2980054845 hasRelatedWork W2014063304 @default.
- W2980054845 hasRelatedWork W2499257614 @default.
- W2980054845 hasRelatedWork W2551747070 @default.
- W2980054845 hasRelatedWork W2554151492 @default.
- W2980054845 hasRelatedWork W2979270751 @default.
- W2980054845 hasRelatedWork W2979738667 @default.
- W2980054845 hasRelatedWork W3021930148 @default.
- W2980054845 hasRelatedWork W4206396850 @default.
- W2980054845 hasRelatedWork W4238928334 @default.
- W2980054845 hasRelatedWork W4379981204 @default.
- W2980054845 hasVolume "128" @default.
- W2980054845 isParatext "false" @default.
- W2980054845 isRetracted "false" @default.
- W2980054845 magId "2980054845" @default.
- W2980054845 workType "article" @default.